Share-based compensation (Details) - CHF (SFr) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Share-based compensation | ||||
| Share-based compensation | SFr 19,181 | SFr 47,226 | SFr 44,098 | SFr 105,572 |
| Discontinued operations | ||||
| Share-based compensation | ||||
| Share-based compensation | 1,485,750 | |||
| Discontinued operations as disclosed below | ||||
| Share-based compensation | ||||
| Accelerated vesting of equity incentive units of employees and Executive Managers transferred to Neurosterix Pharma Sarl | SFr 1,158,069 | SFr 1,158,069 | ||